4.7 Article

Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung

Matthew Gagne et al.

Summary: mRNA-1273 vaccine efficacy against SARS-CoV-2 Delta decreases over time, and protection may be dependent on anamnestic antibody responses. The vaccine provides durable but delayed protection in the lungs, while a boost may be needed for rapid and sustained protection in the upper and lower airways.
Article Biochemistry & Molecular Biology

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

Alison Tarke et al.

Summary: T cell responses induced by different vaccine platforms cross-recognize early SARS-CoV-2 variants, while memory B cells and neutralizing antibodies show significant decreases. The majority of memory T cell responses are preserved against variants, with lower recognition of Omicron by memory B cells.
Article Multidisciplinary Sciences

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann et al.

Summary: The study showed that CoVac-1 vaccine has a favorable safety profile, inducing broad, potent T cell responses that are independent of SARS-CoV-2 variants, supporting its ongoing evaluation in a phase II trial for patients with B cell or antibody deficiency.

NATURE (2022)

Article Multidisciplinary Sciences

Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron

Jinyan Liu et al.

Summary: This study demonstrates that cellular immunity induced by current SARS-CoV-2 vaccines is highly conserved to the Omicron spike protein. Individuals vaccinated with Ad26.COV2.S or BNT162b2 vaccines showed durable spike-specific CD8(+) and CD4(+) T cell responses that were cross-reactive to both the Delta and Omicron variants, including in central and effector memory cellular subpopulations.

NATURE (2022)

Article Immunology

An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Yanchun Peng et al.

Summary: Specific CD8(+) T cell responses targeting NP105-113-B*07:02 are associated with mild COVID-19 disease and high antiviral efficacy, providing potential targets for T cell vaccine design. These T cell responses show long-lasting preservation of antiviral functionality post-infection.

NATURE IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19

Sarthak Sinha et al.

Summary: New findings illuminate the molecular mechanisms of dexamethasone action in severe COVID-19 patients, highlighting the expansion of distinct neutrophil states and altered immune dynamics. These results pave the way for the development of targeted immunotherapies for severe COVID-19 by defining COVID-19-enriched neutrophil states and the molecular mechanisms of dexamethasone action.

NATURE MEDICINE (2022)

Article Biochemistry & Molecular Biology

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

Yu Gao et al.

Summary: This study found that SARS-CoV-2 spike-specific CD4(+) and CD8(+) T cells induced by prior infection or BNT162b2 vaccination provide extensive immune coverage against the Omicron variant. Additionally, T cells induced by BNT162b2 vaccination exhibit higher cross-reactivity to the Omicron variant compared to T cells induced by prior SARS-CoV-2 infection.

NATURE MEDICINE (2022)

Review Biochemistry & Molecular Biology

Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates

Marieke A. Stammes et al.

Summary: CXR, CT, and PET-CT are noninvasive imaging techniques used in human and veterinary pulmonary research. They have been applied to study SARS-CoV-2-exposed non-human primates, providing qualitative and quantitative evaluation of lung disease. However, there is high variability in image acquisition and analysis protocols, calling for standardization improvements.

TRENDS IN MOLECULAR MEDICINE (2022)

Article Immunology

Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients

Corine H. GeurtsvanKessel et al.

Summary: This study demonstrates that vaccinated individuals retain T cell immunity to the SARS-CoV-2 Omicron variant, despite low levels of neutralizing antibodies. Booster vaccinations can partially restore cross-neutralization of the Omicron variant.

SCIENCE IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Roanne Keeton et al.

Summary: Despite reduced neutralizing antibody activity, T cell responses induced by vaccination or infection can cross-recognize the Omicron variant and provide protection.

NATURE (2022)

Review Pathology

Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

Danny Jonigk et al.

Summary: This article discusses the importance of autopsies in the context of the COVID-19 pandemic and presents findings from autopsies conducted in German autopsy centers. The study reveals the distribution of SARS-CoV-2 in various organs and tissues, and provides insights into the pathological features and mechanisms of COVID-19. However, the pathological changes in non-respiratory organs remain unclear.

VIRCHOWS ARCHIV (2022)

Article Immunology

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

Tamara S. Rodrigues et al.

Summary: The active NLRP3 inflammasome in response to SARS-CoV-2 infection is associated with disease severity in COVID-19 patients, with higher levels of IL-18 and Casp1p20 correlating with poor clinical outcomes. These findings suggest that inflammasomes may serve as markers of disease severity and potential therapeutic targets for COVID-19.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Multidisciplinary Sciences

Correlates of protection against SARS-CoV-2 in rhesus macaques

Katherine McMahan et al.

Summary: Adoptive transfer of purified IgG from convalescent macaques protects naive macaques against SARS-CoV-2 infection, and cellular immune responses contribute to protection against rechallenge with SARS-CoV-2. The findings suggest that relatively low antibody titres are sufficient for protection against SARS-CoV-2 in macaques, while higher antibody titres are required for treatment of SARS-CoV-2 infection.

NATURE (2021)

Article Neurosciences

What can we learn from brain autopsies in COVID-19?

Shibani S. Mukerji et al.

Summary: SARS-CoV-2 infection in causing COVID-19 can lead to a range of neurological symptoms, but the underlying mechanisms remain unclear, and the potential for neuroinvasion by the virus is uncertain. Human autopsies have revealed the neuropathological consequences of infection, and incorporating brain tissue research findings into our understanding of clinical disease will guide management and research priorities related to neurological morbidity.

NEUROSCIENCE LETTERS (2021)

Article Multidisciplinary Sciences

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity

Egle Kvedaraite et al.

Summary: This study found that COVID-19 patients experience a redistribution of monocyte subsets towards intermediate monocytes and a general decrease in circulating dendritic cells. Severe disease is associated with the appearance of monocytic myeloid-derived suppressor cell-like cells and a higher frequency of pre-DC2. The phenotypic alterations in mononuclear phagocytes are cell-lineage-specific and linked to the response against SARS-CoV-2 or COVID-19 severity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Article Cell Biology

Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys

Emily Speranza et al.

Summary: This study utilized African green monkeys as models to investigate the dynamics of SARS-CoV-2 virus replication in the respiratory tract. It was found that virus replication mainly occurred in pneumocytes in the lungs, while macrophages drove the inflammatory response. By combining single-cell RNA sequencing and new analysis methods, important cells in the host response to virus infection were identified and their roles elucidated.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Measurement of leukocyte trafficking kinetics in macaques by serial intravascular staining

E. Lake Potters et al.

Summary: Leukocyte trafficking plays a crucial role in homeostasis and immune responses, with dysregulation often observed in disease. The SIVS method developed for measuring trafficking kinetics in nonhuman primates provides valuable insights into the dynamics of immune responses and may aid in understanding disease pathogenesis.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

Kathryn A. Ryan et al.

Summary: The study found that high doses of SARS-CoV-2 in ferrets can cause viral RNA shedding in the upper respiratory tract and lung pathology, while lower doses result in milder pathological symptoms. Ferrets re-challenged after virus shedding ceased are fully protected from acute lung pathology.

NATURE COMMUNICATIONS (2021)

Article Microbiology

Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets

Dhiraj Kumar Singh et al.

Summary: Non-human primate models, particularly macaques and baboons, demonstrate acute respiratory distress and immune responses similar to COVID-19 progression in humans, making them valuable for testing vaccines and therapies. Age appears to affect viral shedding, lung inflammation, and immune response in these animal models.

NATURE MICROBIOLOGY (2021)

Article Immunology

PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques

Keith D. Kauffman et al.

Summary: Blocking PD-1 increases the number and functionality of Mtb-specific CD8 T cells in granulomas of rhesus macaques, but has a lesser impact on CD4 T cells with more of an inhibitory effect.

SCIENCE IMMUNOLOGY (2021)

Article Pathology

Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques

Robert V. Blair et al.

Summary: This study reported two cases of ARDS in AGMs infected with SARS-CoV-2, as well as a comparatively mild COVID-19 phenotype in two surviving AGMs and four infected RMs. The results suggest that aged AGMs may be useful for modeling severe disease manifestations related to COVID-19.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Article Immunology

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Peter A. Szabo et al.

Summary: This study investigated the immune responses in the respiratory tract and blood of severe COVID-19 patients, revealing that T cells in the airways showed protective profiles while myeloid cells exhibited hyperinflammatory signatures. These findings provide important insights for understanding and treating COVID-19 lung pathology.

IMMUNITY (2021)

Article Biochemistry & Molecular Biology

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng et al.

Summary: Defined levels of SARS-CoV-2-specific binding and neutralizing antibodies elicited by the COVID-19 vaccine were identified as correlates of protection against symptomatic infection. Higher levels of immune markers were correlated with a reduced risk of symptomatic infection. The data can be used to extrapolate efficacy estimates to new populations.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters

Xueqiao Liu et al.

Summary: The study developed a promising live intranasal vector vaccine against COVID-19, showing strong immune responses in experiments and broad neutralizing activity against various lineages of SARS-CoV-2.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study

Megan M. Sheehan et al.

Summary: The study found that prior infection in patients with COVID-19 provided a high level of protection against reinfection and symptomatic disease, with this protection increasing over time. This suggests that viral shedding or ongoing immune response may persist beyond 90 days, and may not necessarily represent true reinfection.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission

Shu Horiuchi et al.

Summary: The study found that the innate immune response to SARS-CoV-2 infection was delayed but followed by a pronounced adaptive response, with T cell adoptive transfer reducing virus levels and rapidly inducing specific B cells. SARS-CoV-2-specific T and B cells were able to control infection, but failed to prevent transmission to both naive and vaccinated animals.

SCIENCE IMMUNOLOGY (2021)

Article Immunology

SARS-CoV-2 infection generates tissue-localized immunological memory in humans

Maya M. L. Poon et al.

Summary: Research has shown that SARS-CoV-2-specific immune memory persists in organs for up to 6 months post-infection, with lungs and lymph nodes being the most prevalent sites, indicating coordinated local tissue immunity for protection against future infections.

SCIENCE IMMUNOLOGY (2021)

Article Medicine, General & Internal

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

Christian Holm Hansen et al.

Summary: The study investigated the protection against SARS-CoV-2 reinfection, with results showing an 80.5% protection rate for individuals previously infected. Even in the population aged 65 years and older, the protection rate against reinfection reached 47.1%, with no significant differences observed by gender or time since infection.

LANCET (2021)

Article Medicine, General & Internal

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Victoria Jane Hall et al.

Summary: This study investigated whether antibodies against SARS-CoV-2 were associated with a decreased risk of symptomatic and asymptomatic reinfection. It found that individuals with a previous history of SARS-CoV-2 infection had an 84% lower risk of reinfection, with a median protective effect lasting for 7 months following primary infection.

LANCET (2021)

Article Biochemistry & Molecular Biology

Single-cell multi-omics analysis of the immune response in COVID-19

Emily Stephenson et al.

Summary: Transcriptomic and proteomic profiling of blood samples from individuals with COVID-19 reveals immune cell and hematopoietic progenitor cell alterations that are differentially associated with disease severity.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Article Cell Biology

A cohort autopsy study defines COVID-19 systemic pathogenesis

Xiao-Hong Yao et al.

Summary: The study profiles 26 COVID-19 autopsy cases from Wuhan and determines the systemic distribution of SARS-CoV-2 in critically ill patients. It reveals that SARS-CoV-2 may invade multiple organs and utilize physiological barriers as entry ports for systemic dissemination, shedding light on novel COVID-19 treatment development.

CELL RESEARCH (2021)

Article Immunology

Functional inactivation of pulmonary MAIT cells following 5-OP-RU treatment of non-human primates

Shunsuke Sakai et al.

Summary: In rhesus macaques, MAIT cells show a tendency to lose effector functions rather than expand after TCR stimulation in vivo, which represents a significant barrier to therapeutically targeting these cells.

MUCOSAL IMMUNOLOGY (2021)

Article Immunology

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

Kizzmekia S. Corbett et al.

Summary: The mRNA-1273 vaccine from Moderna in a two-dose regimen provides strong protection against major variants of concern, particularly the B.1.351 variant. Higher neutralizing antibody responses and reduced viral replication in the upper and lower airways were observed after two doses, highlighting the importance of the full vaccine regimen for effective immunity.

NATURE IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

Kizzmekia S. Corbett et al.

Summary: In nonhuman primates (NHPs), vaccination with mRNA-1273 induces dose-dependent antibody responses, leading to a significant reduction in viral replication post SARS-CoV-2 challenge. Replication of the virus correlates strongly with antibody levels and neutralizing activity, with lower levels required in the lower airway than in the upper airway. Passive transfer of mRNA-1273-induced IgG is sufficient to provide protection, indicating that humoral immune responses induced by mRNA-1273 vaccine are effective against SARS-CoV-2 in NHPs.

SCIENCE (2021)

Article Cell Biology

Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants

Abishek Chandrashekar et al.

Summary: Natural immunity induced by the original SARS-CoV-2 WA1/2020 strain provides partial but incomplete protection against the B.1.1.7 (alpha) and B.1.351 (beta) variants. Further research is needed to understand the implications for vaccination and public health strategies in the face of emerging SARS-CoV-2 variants of concern.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Immunology

Evidence for antibody as a protective correlate for COVID-19 vaccines

Kristen A. Earle et al.

Summary: The study found a strong correlation between antibody titers and efficacy when assessing different COVID-19 vaccines, supporting the use of post-immunization antibody titers as the basis for establishing a correlate of protection for COVID-19 vaccines.

VACCINE (2021)

Article Microbiology

Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques

Kim J. Hasenkrug et al.

Summary: The study suggests that T cells are not critical for recovery from acute SARS-CoV-2 infections in rhesus macaques. Instead, B cell responses and antibodies are likely the essential mediators of protection from re-exposure.
Article Multidisciplinary Sciences

Peripheral and lung resident memory T cell responses against SARS-CoV-2

Judith Grau-Exposito et al.

Summary: The study suggests that lung resident memory T cells play a crucial role in limiting the spread of SARS-CoV-2 and COVID-19. Different clinical outcomes are associated with distinct virus-specific T cell responses, and the persistence of antiviral lung T-RM cells in convalescent patients may help limit reinfection.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19

Jason Neidleman et al.

Summary: The study found that individuals who recovered from severe COVID-19 have increased and continuously growing numbers of SARS-CoV-2-specific T cells, whereas fatal cases displayed elevated numbers of SARS-CoV-2-specific regulatory T cells and an escalation in activated bystander CXCR4(+) T cells over time.

CELL REPORTS (2021)

Article Microbiology

Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+T cells in cynomolgus macaques

Takushi Nomura et al.

Summary: SARS-CoV-2 infection presents a wide spectrum of clinical manifestations, but the direct relationship between CD8(+) T cells and viral replication control remains unclear. This study suggests that CD8(+) T-cell depletion in the subacute phase did not significantly impact SARS-CoV-2 replication.

PLOS PATHOGENS (2021)

Letter Medicine, General & Internal

Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy

Jose Vitale et al.

Summary: This cohort study investigates the rate of SARS-CoV-2 reinfection among individuals in Lombardy, Italy, who had previously recovered from COVID-19.

JAMA INTERNAL MEDICINE (2021)

Article Immunology

CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients

Vamsee Mallajosyula et al.

Summary: The study suggests that CD8(+) T cells with conserved specificities are more abundant in COVID-19 patients with mild disease, indicating a potential protective role.

SCIENCE IMMUNOLOGY (2021)

Article Immunology

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

Benjamin Israelow et al.

Summary: Research demonstrates that both humoral and cellular immunity play a role in clearing SARS-CoV-2, and convalescent mice or mice vaccinated with mRNA are protected from infection with both the wild type virus and the B.1.351 variant. This protection is mainly mediated by antibody response rather than cellular immunity.

SCIENCE IMMUNOLOGY (2021)

Article Cell Biology

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

Alison Tarke et al.

Summary: The study showed that SARS-CoV-2 variants do not significantly disrupt total T cell reactivity, although decreases in response frequency of 10%-22% were observed under certain assay/VOC combinations. This underscores the importance of actively monitoring T cell responses in the context of SARS-CoV-2 evolution.

CELL REPORTS MEDICINE (2021)

Article Multidisciplinary Sciences

IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression

Sujan K. Dhar et al.

Summary: This study conducted a comprehensive meta-analysis to establish the association between induced cytokines and COVID-19 disease severity, focusing on 13 cytokines identified from 18 clinical studies. The results showed that IL-6 and IL-10 had statistically significant standardized mean differences across studies, and a classifier built using the mean values of both cytokines as covariates had an accuracy of around 92%, outperforming previous literature using them as individual covariates.

HELIYON (2021)

Article Multidisciplinary Sciences

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice

Jian Zheng et al.

Summary: The COVID-19 pandemic is associated with significant morbidity and mortality. Experimental studies in animals infected with SARS-CoV-2 have revealed severe lung and brain damage, as well as early onset anosmia in mice. Excitingly, infusion of convalescent plasma from recovered patients has shown to protect against lethal disease, though it does not prevent anosmia.

NATURE (2021)

Article Biochemistry & Molecular Biology

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

Pierre Bost et al.

Article Microbiology

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

Young-Il Kim et al.

CELL HOST & MICROBE (2020)

Article Microbiology

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Evangelos J. Giamarellos-Bourboulis et al.

CELL HOST & MICROBE (2020)

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Abishek Chandrashekar et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Jingyou Yu et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Barry Rockx et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Sin Fun Sia et al.

NATURE (2020)

Article Multidisciplinary Sciences

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

Vincent J. Munster et al.

NATURE (2020)

Article Multidisciplinary Sciences

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Linlin Bao et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Mingfeng Liao et al.

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Jonas Schulte-Schrepping et al.

Article Immunology

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling

Benjamin Israelow et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

Article Biochemistry & Molecular Biology

Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques

Malika Aid et al.

Article Multidisciplinary Sciences

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado et al.

NATURE (2020)

Article Multidisciplinary Sciences

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Neeltje van Doremalen et al.

NATURE (2020)

Article Multidisciplinary Sciences

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Carolina Lucas et al.

NATURE (2020)

Article Medicine, General & Internal

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Kizzmekia S. Corbett et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques

Wei Deng et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Article Immunology

Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19

Elizabeth R. Mann et al.

SCIENCE IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates

M. D. Fahlberg et al.

NATURE COMMUNICATIONS (2020)

Article Critical Care Medicine

Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients

Myriam Remmelink et al.

CRITICAL CARE (2020)

Article Biochemistry & Molecular Biology

Age-related rhesus macaque models of COVID-19

Pin Yu et al.

ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2020)

Article Immunology

CD4+ resident memory T cells dominate immunosurveillance and orchestrate local recall responses

Lalit K. Beura et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Review Immunology

Human dendritic cell subsets: an update

Matthew Collin et al.

IMMUNOLOGY (2018)

Article Biotechnology & Applied Microbiology

Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics

Marlon Stoeckius et al.

GENOME BIOLOGY (2018)

Article Immunology

Cutting Edge: Intravascular Staining Redefines Lung CD8 T Cell Responses

Kristin G. Anderson et al.

JOURNAL OF IMMUNOLOGY (2012)